Core Viewpoint - Zhejiang Jinhua New Materials Co., Ltd. is set to go public on July 4 at the Beijing Stock Exchange, focusing on ketoxime series fine chemicals and has become a core supplier in the silane coupling agent and hydroxylamine salt segments in China [1][7] Group 1: Company Overview - The company specializes in silane coupling agents, which are key raw materials for producing organic silicone sealants and adhesives, with applications in construction materials, energy, electronics, and new energy vehicles [1] - Hydroxylamine salts are widely used in the production of pesticides, antibacterial drugs, metal extractants, ion exchange resins, and eco-friendly dyes [1] - The company has established a green circular industry chain for ketoxime series products, achieving significant technological breakthroughs and industrialization [4] Group 2: Investment Projects - The total investment for the core projects is 601 million yuan, with 593 million yuan planned to be raised through the IPO [1] - The 60kt/a high-end coupling agent project will invest 507 million yuan, adding 30,000 tons/year of silane coupling agents and functional silane intermediates [1] - The 500 tons/year JH-2 pilot project has a total investment of 30.58 million yuan, focusing on the production of hydroxylamine aqueous solution, which is a high-value product with significant market potential [3] Group 3: Market Demand and Growth - Global consumption of functional silanes has increased from 103,000 tons in 2002 to 525,500 tons in 2023, with projections to reach 719,000 tons by 2028 [2] - The demand for functional silanes is driven by both traditional sectors and emerging fields such as composite materials, providing new growth points for the company [2] - The company has maintained a strong growth trajectory, with projected revenues of 994 million yuan, 1.115 billion yuan, and 1.239 billion yuan from 2022 to 2024 [5] Group 4: Financial Performance - The company’s net profit is expected to rise from 80 million yuan in 2022 to 211 million yuan in 2024, indicating a significant enhancement in profitability [5] - The gross profit margin has improved from 17.72% in 2022 to 27.94% in 2024, while the debt-to-asset ratio has decreased from 44.45% to 27.94% [5] - Research and development investment has averaged 51.68 million yuan annually over the past three years, representing 4.63% of revenue, with a compound annual growth rate of 9.11% [5] Group 5: Market Position - The company’s market share for silane coupling agents is projected to increase from 27.85% in 2022 to 38.16% in 2024 [7] - For hydroxylamine salts, the market share is expected to rise from 34.86% in 2022 to 42.37% in 2024 [7] - The company aims to leverage its technological advantages and market position to expand its business scale and meet growing market demands [7]
领跑酮肟系列精细化学品国产替代 锦华新材冲刺北交所IPO
Quan Jing Wang·2025-08-13 05:51